Aatmaj Healthcare Ltd
Aatmaj Healthcare Q1 FY27: Revenue ₹8.13 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Aatmaj Healthcare Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.
The short version
Revenue for Q1 FY 2026-27: ₹8.13 crore - Revenue for Q1 FY 2025-26: ₹5.05 crore - Year-on-year revenue growth: 61% increase (from ₹5.05 crore to ₹8.13 crore) - Profit before tax & depreciation for Q1 FY 2026-27: ₹1.52 crore - Profit before tax & depreciation for Q1 FY 2025-26: ₹0.55 crore - Year-on-year profit growth: 170% increase - Old debt recovery during Q1 FY 2026-27: ~5% - Outlook: Expected revenue for FY 2026-27 from Anand Hospital expansion estimated at ₹9–9.5 crore; expected profit before tax & depreciation ₹2.5–3 crore. EBITDA: ₹1.52 crore for Q1 FY 2026-27 (no prior year EBITDA figure explicitly stated for comparison).
From Aatmaj Healthcare Ltd's Q1 FY27 earnings-call transcript · updated 18 Oct 2026.
Revenue & Sales Performance
- Revenue for Q1 FY 2026-27: ₹8.13 crore
- Revenue for Q1 FY 2025-26: ₹5.05 crore
- Year-on-year revenue growth: 61% increase (from ₹5.05 crore to ₹8.13 crore)
- Profit before tax & depreciation for Q1 FY 2026-27: ₹1.52 crore
- Profit before tax & depreciation for Q1 FY 2025-26: ₹0.55 crore
- Year-on-year profit growth: 170% increase
- Old debt recovery during Q1 FY 2026-27: ~5%
2 more points from Aatmaj Healthcare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Aatmaj Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Expansion of specialty services with launch of:
- Dedicated Cardiothoracic & Vascular Surgery (CTVS) Department at Jupiter Hospital, Atladara, Vadodara.
- JTP IVF & Fertility Centre at Karelibaug, Vadodara.
- Facilities equipped with modern infrastructure and experienced professionals.
- Aim: Enhance clinical capabilities, patient access, and long-term growth.
- Acquisition of Anand Hospital, Anand Shri Laboratory, and Anand Shri Pharmacy in Nizampura, Vadodara:
- Expected Revenue (2026–27): INR 9 - 9.5 crore.
- Expected Profit Before Tax & Depreciation (2026–27): INR 2.5 - 3 crore.
2 more points from Aatmaj Healthcare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Aatmaj Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Continue your research
What Aatmaj Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Asarfi Hospital (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
- Thyrocare Tech. (Q1 FY27)
Pathology business grew ~27%; franchisee business grew ~23-27% YoY, reflecting strong volume growth. Key concall takeaways from Thyrocare Technologies Ltd's Q1…
Arthneeti Pro · Annual
Aatmaj Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Aatmaj Healthcare Ltd Q1 FY27 results?
Revenue for Q1 FY 2026-27: ₹8.13 crore - Revenue for Q1 FY 2025-26: ₹5.05 crore - Year-on-year revenue growth: 61% increase (from ₹5.05 crore to ₹8.13 crore) - Profit before tax & depreciation for Q1 FY 2026-27: ₹1.52 crore - Profit before tax & depreciation for Q1 FY 2025-26: ₹0.55 crore - Year-on-year profit growth: 170% increase - Old debt recovery during Q1 FY 2026-27: ~5% - Outlook: Expected revenue for FY 2026-27 from Anand Hospital expansion estimated at ₹9–9.5 crore; expected profit before tax & depreciation ₹2.5–3 crore. EBITDA: ₹1.52 crore for Q1 FY 2026-27 (no prior year EBITDA figure explicitly stated for comparison).
What is Aatmaj Healthcare Ltd share price analysis?
Aatmaj Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 69.1 with a market cap of ₹50 Cr. Investors should review the full earnings analysis for detailed insights.
Is Aatmaj Healthcare Ltd planning capital expenditure?
Expansion of specialty services with launch of: - Dedicated Cardiothoracic & Vascular Surgery (CTVS) Department at Jupiter Hospital, Atladara, Vadodara.
Keep Aatmaj Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.